Stemcentrx

Stemcentrx is a South San Francisco, California based biotech company that was acquired by AbbVie for $5.8B on Apr 28, 2016.


  

Acquired by AbbVie for $5.8B on Apr 28, 2016.


  

  • Year founded: 2008
  • Funding Info: $515.5M in 4 funding rounds (Last funding type: Series G)
  • Yearly Revenue: $25M-$35M(2017)
  • Employee Size: 51-200
  • City/Town: San Francisco
  • State: California
  • Country: United States
Related businesses